Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis.
Axon injury is a major determinant of the loss of neurological function in patients with multiple sclerosis. It is unclear, however, whether damage to axons is an obligatory consequence of demyelination or whether it is an independent process that occurs in the permissive environment of demyelinated lesions. Previous investigations into the role of CD8 T cells and perforin in the Theiler murine encephalomyelitis virus model of multiple sclerosis have used mouse strains resistant to Theiler murine encephalomyelitis virus infection. To test the role of CD8 T cells in axon injury, we established a perforin-deficient mouse model on the H-2 major histocompatibility complex background thereby removing confounding factors related to viral biology in this Theiler murine encephalomyelitis virus-susceptible strain. This permitted direct comparison of clinical and pathological parameters between perforin-competent and perforin-deficient mice. The extent of demyelination was indistinguishable between perforin-competent and perforin-deficient H-2 mice, but chronically infected perforin-deficient mice exhibited preservation of motor function and spinal axons despite the presence of spinal cord demyelination. Thus, demyelination is necessary but insufficient for axon injury in this model; the absence of perforin protects axons without impacting demyelination. These results suggest that perforin is a key mediator of axon injury and lend additional support to the hypothesis that CD8 T cells are primarily responsible for axon damage in multiple sclerosis.
Deb
Chandra
C
Departments of Neurology, Mayo Clinic, Rochester, Minnesota.
Lafrance-Corey
Reghann G
RG
Zoecklein
Laurie
L
Papke
Louisa
L
Rodriguez
Moses
M
Howe
Charles L
CL
D000818:Animals; D001369:Axons / Q000276:immunology / Q000473:pathology*; D001921:Brain / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D018188:Cardiovirus Infections / Q000235:genetics / Q000276:immunology; D003711:Demyelinating Diseases / Q000235:genetics* / Q000276:immunology / Q000503:physiopathology; D004195:Disease Models, Animal; D005434:Flow Cytometry; D015870:Gene Expression; D020869:Gene Expression Profiling; D006183:H-2 Antigens / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009103:Multiple Sclerosis / Q000235:genetics* / Q000276:immunology / Q000503:physiopathology*; D054353:Perforin / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D017945:Theilovirus / Q000235:genetics / Q000276:immunology
D006183:H-2 Antigens; D054353:Perforin
Brain Pathol. 2003 Jul;13(3):291-308
12946019
Eur J Immunol. 1993 Sep;23(9):2287-93
8370406
Am J Pathol. 2001 Sep;159(3):809-15
11549572
J Clin Invest. 2008 Apr;118(4):1532-43
18340379
J Neurovirol. 2008 May;14(3):261-6
18569460
Brain Pathol. 1999 Jan;9(1):21-31
9989447
Am J Pathol. 2006 Sep;169(3):999-1011
16936273
J Neuroimmunol. 2007 Nov;191(1-2):79-85
17920696
Future Virol. 2008;3(6):579-593
19079794
J Neurosci. 1998 Sep 15;18(18):7306-14
9736651
Am J Pathol. 2003 Apr;162(4):1259-69
12651618
J Virol. 1993 Jan;67(1):589-92
8416386
Brain. 2000 Jun;123 ( Pt 6):1174-83
10825356
J Exp Med. 2000 Aug 7;192(3):393-404
10934227
J Neurovirol. 2001 Oct;7(5):409-20
11582513
Infect Immun. 1975 May;11(5):1147-55
164412
Brain Pathol. 2004 Jan;14(1):43-50
14997936
J Neuropathol Exp Neurol. 2007 Sep;66(9):828-37
17805013
Neurobiol Dis. 2007 Feb;25(2):354-9
17112732
Ann Neurol. 2008 Apr;63(4):428-35
18438950
J Virol. 2001 Aug;75(16):7420-8
11462014
Lab Invest. 1991 Mar;64(3):358-70
2002654
Nat Med. 1998 Feb;4(2):187-193
9461192
J Neuropathol Exp Neurol. 2007 Apr;66(4):295-304
17413320
Nat Rev Neurosci. 2006 Dec;7(12):932-41
17115075
Am J Pathol. 2008 Jul;173(1):93-105
18535178
Trends Immunol. 2008 Feb;29(2):54-60
18182323
Ann Neurol. 2006 Mar;59(3):478-89
16392116
J Neuroimmunol. 2007 Aug;188(1-2):13-21
17493690
J Neuroimmunol. 2001 Jun 1;116(2):125-35
11438167
Springer Semin Immunopathol. 2002;24(2):105-25
12503060
J Virol. 1998 Sep;72(9):7320-9
9696828